Please Wait
Applying Filters...
menu
    • menu
    Top news of 2025: Drugmakers invest in US capacities, agree to lower Medicaid prices; Pfizer buys obesity-focused biotech Metsera

    Data Compilation
    #PharmaFlow

    Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

    Stock Recap
    #PipelineProspector

    Menu

    Beta Nicotinamide Adenine Dinucleotide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 136Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Labeler NDC Package Code Non Proprietary Name Start Marketing Date End Marketing Date Category Code Dosage Form (Strength)
    06/01/2026 Ax Pharmaceutical Corporation
    Canada
    		 AX Pharmaceutical Corp 73377-339 Nicotinamide Adenine Dinucleotide 2025-12-03 2026-12-31 BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING POWDER (1g/g)
    30/12/2025 Biopeptek Pharmaceuticals
    U.S.A
    		 Qingdao Biopeptek Co., Ltd. 73212-032 NAD (BETA) 2022-01-03 2025-12-31 BULK INGREDIENT POWDER (1g/g)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.